Universal Program Number: 207-000-07-083-H01
Pharmacy CE Release Date: May 23, 2007
Pharmacy CE Expiration Date: May 23, 2010
Case Manager CE Release Date: May 23, 2007
Case Manager CE Expiration Date: May 23, 2008
In 2003, Chronic Obstructive Pulmonary Disease (COPD) was
listed as the fourth leading cause of death in America. In 2004, 11.4 million
U.S. adults (aged 18 and over) were estimated to have COPD, costing the nation
approximately $37.2 billion in health care expenditures.
for COPD can only be effective and improve patient outcomes if they are utilized.
Studies have shown that adult patients with minimal to moderate airflow limitation
who were instructed to utilize bronchodilators three times each day experienced
better adherence following study visits. However, adherence with bronchodilators
declined in the time between visits. The same study indicated non-adherence is
a serious complicating factor in COPD management.
Medicare Modernization Act brings Medication Therapy Management to the forefront
in health care with management of respiratory diseases expressly mentioned in
the legislation. Specifically stated, medication therapy management is mandated
for targeted high risk beneficiaries, those determined to have multiple chronic
disease states, multiple medications, and high drug spend, presenting an opportunity
for pharmacists to interact with these at-risk beneficiaries to improve outcomes.
and key team members caring for COPD patients have a huge opportunity
to manage the medication therapy of these patients, including
counseling and continually reinforcing the importance of adherence
to these medicines. Pharmacists and case managers can serve
as a conduit for education regarding appropriate dosing and
timing of regularly scheduled and as needed medications, the
proper technique for inhaled medications, and provide ongoing
monitoring and information for family members and caregivers.
It is important that pharmacists and case managers are up to
date on current COPD recommendations so they can recommend appropriately
and provide the most comprehensive COPD medication therapy management
possible. According to the 2006 NCPA-Pfizer Digest, community
pharmacists discuss drug therapy with prescribers, on average,
more than eight times a day.